| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Nephrogenesis 0.8679878048780603 2.7829404163796747 0.0053868698006649 0.960869723663071 0.0808030470099741 2 Q04721 1 |
| Rala downstream regulated genes 0.8700894428919093 2.764079600818943 0.00570836118742 0.967769101007842 0.0815480169631431 4 Q96KP1 1 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.8335851537935348 2.600656223511732 0.0093045643205129 0.9963348034221468 0.1015043380419596 4 P20700,Q03252 2 |
| Interactome of polycomb repressive complex 2 prc2 0.7795694596877409 2.338277960156362 0.0193728335741107 0.9999920135784176 0.1325894464566993 5 P55199,Q9Y2W1 2 |
| Mrna processing 0.3717740879731789 2.2361215239089036 0.0253438118999889 0.9999997954183464 0.1526038669872562 102 P33240,P61978,Q13435,P67809,P08579,Q12996,O43395,P23246,P38159,P84103,Q86U42,Q7RTV0,Q6P2Q9,P49755,O43390,O95319,Q16629,O95400,P07910,Q15428,Q13242,Q99729,P62995,O00267,Q07955,O75400,Q14103,P09012,Q14683,P22626,Q8IX01,P55795,O60508,Q8WXA9,Q8IYB3,Q15459,P24928,O75937,O75494,P09661,P08621,Q13247,O43148,P35637,Q13523,Q15427 46 |
| Nad metabolism sirtuins and aging 0.7259871312889916 2.1003847844645835 0.0356950063894845 0.999999999662208 0.1784750319474226 4 Q00059 1 |
| Ketone bodies synthesis and degradation 0.7043732374748506 2.0132575931768444 0.0440875371400415 0.999999999998218 0.205058312279263 3 P35914 1 |
| Urea cycle and related diseases 0.6990853658536791 2.005137364136453 0.0449483639862806 0.9999999999989622 0.2062814612549064 2 Q9Y619 1 |
| Interactions between loxl4 and oxidative stress pathway 0.6738865161684 1.8484299274569929 0.0645401726283867 1.0 0.2569011573849454 4 Q8TAG9,Q9BQ95,Q96EB6 3 |
| Dopamine metabolism 0.6615853658536583 1.8233168850503507 0.0682554104056656 1.0 0.2569011573849454 2 P17612 1 |
| Glial cell differentiation 0.6606707317073237 1.818844586626709 0.0689351438982937 1.0 0.2569011573849454 2 P26038 1 |
| Gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases 0.6304350267647414 1.651764982765215 0.0985824697295827 1.0 0.3221659905588845 3 O75223 1 |
| Familial partial lipodystrophy fpld 0.6421619113184678 1.6445718305541883 0.1000581399763098 1.0 0.3237512887889226 7 P20700,O60725,Q03252 3 |
| Ddx1 as a regulatory component of the drosha microprocessor 0.632255758307179 1.6430968354422597 0.100362899524566 1.0 0.3237512887889226 4 P49959,O60934 2 |
| Oxysterols derived from cholesterol 0.6350642320509845 1.609089244179726 0.1075968287881545 1.0 0.3357809552713844 7 Q15125 1 |
| Complement system 0.6403704041965299 1.608552949545507 0.1077141293688646 1.0 0.3357809552713844 9 P39019,Q07021 2 |
| Somatroph axis gh and its relationship to dietary restriction and aging 0.6103658536585471 1.5704287162935189 0.1163154061129074 1.0 0.3421041356261984 2 Q96EB6 1 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.6220730991445436 1.558667924055505 0.119074997375657 1.0 0.3445910333846967 6 O75367,Q16527 2 |
| Eukaryotic transcription initiation 0.6385995629922157 1.523823645161214 0.1275527712261599 1.0 0.3627093020649097 16 O15160,Q9NVU0,Q00403,P29083 4 |
| Nipbl role in dna damage cornelia de lange syndrome 0.6023177798109205 1.511685050172442 0.130614003581543 1.0 0.3662074866772235 3 Q13185,Q14676 2 |
| Monoamine transport 0.5932926829268289 1.485188343520644 0.1374939389333076 1.0 0.3708049423711984 2 O15127 1 |
| Mammary gland development pathway involution stage 4 of 4 0.5902439024390281 1.469928334931935 0.1415811644949622 1.0 0.3760258226372347 2 P40763 1 |
| Smc1smc3 role in dna damage cornelia de lange syndrome 0.5946769861148794 1.3915448835134985 0.1640602590737201 1.0 0.4067609729100499 8 Q92878,Q14676,Q14683,P38398,O60934,P49959 6 |
| Riboflavin and coq disorders 0.5733902960024304 1.3307146747891931 0.1832829125519111 1.0 0.4312317053786632 5 Q8NI60,Q8NFF5,P13804,Q5T2R2 4 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.5793497191332226 1.3285629742977358 0.1839921942948963 1.0 0.4312317053786632 7 P20339 1 |
| Preimplantation embryo 0.5704191230722859 1.298692342763912 0.1940495329632701 1.0 0.4426985542888291 6 Q99729,Q15717,P51532 3 |
| Mir124 predicted interactions with cell cycle and differentiation 0.5533536585365848 1.2846559498628554 0.1989125378389813 1.0 0.4519486139777888 2 P26599 1 |
| Mitochondrial gene expression 0.5705710340670069 1.2695011862395318 0.2042623677255655 1.0 0.4573038083408183 8 Q96E29,Q8WVM0,Q00059,Q08209 4 |
| Progeriaassociated lipodystrophy 0.5717456709823846 1.2613628301464477 0.2071781537410943 1.0 0.4618038542400516 9 P20700,O60725,Q03252 3 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.5395766878702855 1.1963821020170806 0.2315474825450261 1.0 0.4997427680827901 3 P08195 1 |
| Robo4 and vegf signaling pathways crosstalk 0.5259146341463412 1.146644939532368 0.2515283951976865 1.0 0.5242986190219947 2 P63000 1 |
| Extracellular vesiclemediated signaling in recipient cells 0.5262860725710623 1.1295698825826572 0.258657507576401 1.0 0.53269961092408 3 Q9NWH9 1 |
| Caloric restriction and aging 0.5233727759217206 1.096599385907577 0.2728165560632996 1.0 0.550917024057751 4 P42345,Q96EB6 2 |
| Osteoblast differentiation and related diseases 0.5186745461885408 1.0078573446799584 0.3135229516954556 1.0 0.59908844273017 8 O00443 1 |
| Nanoparticle triggered autophagic cell death 0.4986276303751292 0.9912517251302936 0.3215626790225951 1.0 0.6067220358916889 3 Q9Y371,Q13111 2 |
| Gastric cancer network 2 0.532453297585913 0.9886047195563996 0.3228565761947166 1.0 0.6068550499142805 15 Q03252,Q86UE4,Q9HB71,Q6PL18,Q658Y4,Q03701,Q14739,P11388 8 |
| Nanomaterial induced apoptosis 0.4937502800049839 0.9313306213048792 0.3516825668524705 1.0 0.633662282617064 5 O95831 1 |
| Cytoplasmic ribosomal proteins 0.4387615651683008 0.8782645636592037 0.3798001616857704 1.0 0.6669807128791814 75 P42766,P18124,P39019,P62750,P62081,P46783,P61353,P62899,P62841,P62847,P62277,P62273,P61254,P62269,P05387 15 |
| Apoptosis modulation by hsp70 0.4801628227006232 0.8645270595713953 0.3872984220479427 1.0 0.673562473126857 5 O95831 1 |
| Glycerophospholipid biosynthetic pathway 0.4913760607812997 0.858299330662917 0.3907271989500378 1.0 0.6775616166763662 9 Q9BTU6,O95674,Q86UL3,P48651 4 |
| Lung fibrosis 0.4780807960501336 0.8375925948869554 0.4022595531815431 1.0 0.692027641414309 6 P09601 1 |
| Cytosolic dnasensing pathway 0.4939959639386122 0.8317303117354442 0.4055611871443565 1.0 0.692027641414309 12 O15160,Q7Z434 2 |
| Endoplasmic reticulum stress response in coronavirus infection 0.4824552485611976 0.8289319251336597 0.4071429290320851 1.0 0.692027641414309 8 Q12972 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.4846831614721295 0.7989164862001562 0.4243388387915465 1.0 0.7084796130677259 11 Q96AY3,P13674,P50454 3 |
| Amyotrophic lateral sclerosis als 0.4808584630513854 0.7804072650239587 0.4351511929596232 1.0 0.709485640695038 11 P07197,Q9UER7 2 |
| Apoptosis modulation and signaling 0.4762564488376457 0.7224586621504075 0.4700125317033645 1.0 0.7560523298177445 14 O95831,P55212,Q07820,Q9UER7 4 |
| Glucocorticoid receptor pathway 0.4482715734457198 0.6950283407208854 0.4870375408984251 1.0 0.7813436485001473 6 Q12802 1 |
| Omega3 omega6 fatty acid synthesis 0.4423076923076943 0.6672183047579207 0.5046327005340578 1.0 0.7997855234700484 6 Q15067,O95864,O60488,O15254,O95573 5 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.4593436836840389 0.6322079202500852 0.527251022578278 1.0 0.820716297829663 15 P41567,O75821,O75822 3 |
| Oxidative phosphorylation 0.4780775325585517 0.6127158369679159 0.5400642490143874 1.0 0.8367910416354908 31 O75787,O75964,P48047,P06576,P56385,O43674 6 |
| Histone modifications 0.4420864476842566 0.611112849654743 0.5411248735909506 1.0 0.8367910416354908 10 P62805 1 |
| Fas ligand pathway and stress induction of heat shock proteins 0.4536930980176948 0.606270947918183 0.544334847095111 1.0 0.8395910237970865 15 P20700,Q9UER7,Q03252 3 |
| Mitochondrial immune response to sarscov2 0.4348299306446328 0.591186042991452 0.5543957733073857 1.0 0.8529165743190549 9 Q9Y276,Q99623,Q9BQ95,Q7Z434 4 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.4076951550967008 0.558373922147298 0.5765890763602619 1.0 0.8671712547388222 3 Q9P2K5 1 |
| Hematopoietic stem cell gene regulation by gabp alphabeta complex 0.4024665606146769 0.5196323999645189 0.6033198112975255 1.0 0.8895547445567293 4 Q07820 1 |
| Hostpathogen interaction of human coronaviruses autophagy 0.3982921622445953 0.5172681998378587 0.6049689495367776 1.0 0.8895547445567293 3 Q9NT62,P42345 2 |
| Photodynamic therapyinduced ap1 survival signaling 0.4045544557994032 0.4725487247238832 0.636535171714042 1.0 0.9093359595914886 8 Q07820 1 |
| Pparalpha pathway 0.3958370869264901 0.4491551380794962 0.6533197473253347 1.0 0.9245090764037756 7 P09110,P50416,P11802,P23786 4 |
| Liver x receptor pathway 0.3746951219512189 0.4338389500756473 0.6644053949710054 1.0 0.9335907189288132 2 O00767 1 |
| Prostaglandin synthesis and regulation 0.3869470843546128 0.4259022690865505 0.6701790614306551 1.0 0.9351335740892862 6 P08133,P04083,P09525 3 |
| Omega9 fatty acid synthesis 0.375152625152627 0.3795931505039178 0.7042474460277244 1.0 0.9686249969321749 6 P33121,O00767,O95864,O60488,O95573 5 |
| Tumor suppressor activity of smarcb1 0.4018568581197103 0.3772930592882344 0.7059558296063655 1.0 0.9686249969321749 16 P42771,O14497,Q969G3,Q92922,Q96GM5,P11802,P51532,Q12824,Q8TAQ2 9 |
| Energy metabolism 0.3970240085751876 0.3768039719871738 0.7063192887343883 1.0 0.9686249969321749 14 Q8WVM0,Q00059,Q96EB6 3 |
| 7oxoc and 7betahc pathways 0.3803693870766976 0.3645378258701618 0.715456433076775 1.0 0.9691508507736164 9 Q15125 1 |
| Type 2 papillary renal cell carcinoma 0.3766759486774472 0.3618043949304217 0.7174982076611287 1.0 0.9691508507736164 8 Q92733 1 |
| Male infertility 0.402189750750836 0.3338640250564287 0.7384821674974393 1.0 0.9830193376221008 22 Q9UFC0,P62805,Q01831 3 |
| Gastric cancer network 1 0.3792477981044752 0.3296779482015979 0.7416433178204542 1.0 0.9830193376221008 12 P62805,P11388,Q9H8V3 3 |
| Heme biosynthesis 0.3520439292251472 0.3195196842937193 0.7493324671524688 1.0 0.9881307259153436 4 P36551,P08397,P22830 3 |
| Influence of laminopathies on wnt signaling 0.3618912610752607 0.2882212306434844 0.7731773983204879 1.0 1.0 10 Q5JTV8,P50402,O60725 3 |
| Oxidation by cytochrome p450 0.3444980207825145 0.270341750606954 0.7868973483427668 1.0 1.0 6 O43169 1 |
| Nucleotide excision repair 0.3809578880496439 0.244789032288988 0.8066197865762592 1.0 1.0 25 P54727,Q01831,Q9Y2S7,P18858,P41208,P41440 6 |
| Hair follicle development organogenesis part 2 of 3 0.3294691885296019 0.244023696218211 0.8072124676491219 1.0 1.0 4 P05556,P13591,P35222 3 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.3583983723139972 0.2426449316897584 0.8082804707111513 1.0 1.0 14 P11802,P42167,P50402,P55209,O60725 5 |
| Glycogen synthesis and degradation 0.3654266438571644 0.2426327605450843 0.808289900180309 1.0 1.0 17 P11216,P0DP25 2 |
| Mecp2 and associated rett syndrome 0.3740670975245093 0.2385674043753005 0.8114410429042374 1.0 1.0 22 Q8NAV1,P67809 2 |
| Genes controlling nephrogenesis 0.3302111501952676 0.2164605232989887 0.8286287935366283 1.0 1.0 7 Q04721 1 |
| Apoptosis 0.3448066954723543 0.2097577552042139 0.8338567459703068 1.0 1.0 13 P55212,Q07820 2 |
| Fluoroacetic acid toxicity 0.3158376563930227 0.1940408873550216 0.8461438668075951 1.0 1.0 5 Q99798,P51648,P05091,O75390 4 |
| Nucleotide excision repair in xeroderma pigmentosum 0.3741422102500697 0.1921599967791194 0.8476168798479222 1.0 1.0 35 P54727,Q01831,P62805,Q9Y2S7,P18858,P41208,P41440 7 |
| Vitamin b12 disorders 0.3040561146691087 0.1808059633028816 0.8565198822195168 1.0 1.0 3 P22033,Q99707 2 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.3151330393267088 0.1751080425151296 0.8609947388986612 1.0 1.0 7 P05556,Q9Y6E0 2 |
| Mitochondrial complex i assembly model oxphos system 0.3575758826738389 0.1629909838332889 0.8705255336015358 1.0 1.0 29 O43674,Q9P0J0 2 |
| Microtubule cytoskeleton regulation 0.3327438452449463 0.1480895821953436 0.8822720709972474 1.0 1.0 18 P16949 1 |
| Hippomerlin signaling dysregulation 0.3226808553683559 0.1306136627169517 0.8960809340386997 1.0 1.0 17 P62140,P05556,Q13619,Q9NWH9,Q9Y6E0 5 |
| Vitamin d receptor pathway 0.3012617170780256 0.1119763129759148 0.9108421879404154 1.0 1.0 12 Q96KA5,Q92604,P42771,P09493 4 |
| Hedgehog signaling pathway wp4249 0.2729490698383647 0.1096860598285554 0.9126583563486704 1.0 1.0 3 P17612,P32121 2 |
| Valproic acid pathway 0.2836641221373982 0.105414571680389 0.916046853956686 1.0 1.0 7 P45954,Q99714,Q13547,P40939,P26440,P80404 6 |
| Dna mismatch repair 0.3128811149612197 0.0990656411584773 0.9210861522388872 1.0 1.0 20 Q9Y2S7,Q9UQ84,P18858 3 |
| Triacylglyceride synthesis 0.2685910017565255 0.0899055170593852 0.9283622969305356 1.0 1.0 5 Q9NUQ2 1 |
| Fbxl10 enhancement of maperk signaling in diffuse large bcell lymphoma 0.2732733499451811 0.087350774090678 0.9303926963310328 1.0 1.0 7 O75367 1 |
| 1q211 copy number variation syndrome 0.2702801094032159 0.0739166172594339 0.9410767333586982 1.0 1.0 9 Q07157,Q9Y624 2 |
| Calcium regulation in cardiac cells 0.3081836485107056 0.068168457983946 0.945651535427136 1.0 1.0 29 P31946,P23634,P0DP25 3 |
| Mesodermal commitment pathway 0.2952424400224258 0.0660704736739749 0.947321718065634 1.0 1.0 22 Q16204,Q07021,O75925,Q16527 4 |
| Praderwilli and angelman syndrome 0.260950738411467 0.0651088613587267 0.9480873250612196 1.0 1.0 8 P42771 1 |
| Hippo signaling regulation pathways 0.2793199423857214 0.0649089060773372 0.9482465295257756 1.0 1.0 15 Q9NWH9,Q9Y6E0,P04899 3 |
| Atm signaling pathway 0.2777918554590375 0.0629725788484933 0.9497883398792886 1.0 1.0 15 Q12888,P24941,Q14676,O60934,P38398,P49959 6 |
| Network map of sarscov2 signaling pathway 0.3007906943023419 0.0571419101806633 0.954432151447644 1.0 1.0 30 Q96AX1,Q07021,O75925 3 |
| Joubert syndrome 0.2700721972994678 0.0566288932554576 0.9548408179800074 1.0 1.0 14 O75695,P41208 2 |
| Electron transport chain oxphos system in mitochondria 0.304562379442534 0.0487482819034451 0.9611198981929489 1.0 1.0 48 P13073,O75964,P48047,P06576,P56385,P24539,O43674 7 |
| Endochondral ossification with skeletal dysplasias 0.2334622253958633 0.04442414726656 0.9645663139109456 1.0 1.0 5 P17612,P50454 2 |
| Endochondral ossification 0.2334622253958633 0.04442414726656 0.9645663139109456 1.0 1.0 5 P17612,P50454 2 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.2661323135529998 0.03216304408826 0.9743420274668566 1.0 1.0 25 Q15125,Q15126,Q15392 3 |
| Head and neck squamous cell carcinoma 0.2407754018137796 0.0276093096905121 0.97797375643779 1.0 1.0 16 P42771,Q04721 2 |
| Dna irdouble strand breaks and cellular response via atm 0.2452945990428311 0.0214448080609655 0.9828908301090752 1.0 1.0 24 Q12888,P42771,Q9UQ84,O60934,Q14676,P38398,Q9Y6E0,P49959 8 |
| Egfegfr signaling pathway 0.2628554237604183 0.0194928004252257 0.9844479803817234 1.0 1.0 42 O95782,P20339,Q9P0J0,P16949 4 |
| Atm signaling in development and disease 0.2256302759626319 0.0157156944726663 0.987461206165019 1.0 1.0 22 O75150,Q12888,Q92878,O60934,Q14683,Q14676,Q14739,P49959 8 |
| Ebola virus infection in host 0.2359560864536647 0.0125787579889315 0.9899638678686766 1.0 1.0 37 Q96AX1,Q07021 2 |
| Pathogenic escherichia coli infection 0.1981851813860652 0.0106941274785392 0.9914674834298955 1.0 1.0 21 Q92974,P19338,P05556,P15311 4 |
| Tryptophan metabolism 0.1751701407295319 0.0099947547452527 0.9920254722693768 1.0 1.0 14 P35610,Q99714,P51648,Q15392,Q16836,P05091 6 |
| 7q1123 copy number variation syndrome 0.2049524698872265 0.0081682235704011 0.9934827729955014 1.0 1.0 43 P48047,P06576,Q8N5M1 3 |
| Retinoblastoma gene in cancer 0.1746804900954258 0.0071355331572868 0.99430671657379 1.0 1.0 48 O75419,Q9Y619,P16949,Q16204,P00374,P11388 6 |
|
|
